Through our conferences and institutional research activities, we foster scientific exchange, sharing knowledge and expertise while promoting dialogue between research and clinical practice.
2026 Participations
15–17 July 2026 | International Conference on Lymphocyte Engineering
Milan, Italy
Poster selected as the second-place winner: Anti-GD2 CAR T Cells Efficiently Target Ewing’s Sarcoma.
8–11 June 2026 | EACR 2026
Budapest, Hungary
Poster: Valentina Masciale, Proteasome inhibition overcomes TRAIL resistance and enhances MSC-sTRAIL activity in malignant pleural mesothelioma.
6–9 May 2026 | ISCT 2026 Annual Meeting
Dublin, Republic of Ireland
Poster: Immunogenomic Profiling Reveals Targets for Gene Therapy in Pediatric Brain Tumors.
13 April 2026 | OrthoAlloUnion Annual Meeting 2026
Virtual
Invited speaker: Ilenia Mastrolia, WP4: Multimodal potency assays for bone formation of MSC to select suitable donors for the allogeneic cell master bank.
18–19 March 2026 | High-Content CRISPR Screening Conference
Vienna, Austria
Poster: Optimization of CRISPR/Cas9 gene editing strategies for Periostin downregulation in tumor and stromal compartments uncovers its context-dependent role in PDAC.
2025 Participations
4–6 December 2025 | Melanoma Bridge
Naples, Italy
Invited speaker: Giuseppe Pugliese, Autologous anti-GD2 CAR T cells as a preclinical strategy to target cutaneous melanoma.
4 December 2025 | Precision medicine workshops designing the smart and personalized healthcare of the future
Pilot Program for the Network of Digital Centers of Precision Medicine, Rome, Italy
Invited speaker: Chiara Chiavelli, Enabling Technologies and Advanced Therapies for Precision Medicine.
20–22 September 2025 | 5th International Conference on Lymphocyte Engineering
Munich, Germany
Poster: A Preclinical Platform Challenging Malignant Melanoma by Autologous CAR T.
22–24 May 2025 | 9th Cancer World Congress
Prague, Czech Republic
Oral presentation: Valentina Masciale
Poster: Valentina Masciale, Modified MSC as gene therapy tool for refractory solid tumor.
5–7 March 2025 | OrthoAlloUnion Annual Meeting 2025
Madrid, Spain
Invited speaker: Ilenia Mastrolia, WP2: Production of the combined ATMP; WP4: Multimodal potency assays for bone formation of MSC to select suitable donors for the allogeneic cell master bank.
8 May 2022 | Action Conference – Alliance for Advanced Therapies in Orthopaedics
Berlin, Germany
Invited speaker: Ilenia Mastrolia, Predicting Osteogenic Function and Signature in Autologous MSC.